台股 » 個股 » 中裕 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

中裕

(4147)
可現股當沖
  • 股價
    77.8
  • 漲跌
    ▼1.1
  • 漲幅
    -1.39%
  • 成交量
    475
  • 產業
    上櫃 生技醫療類股
  • 321人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
中裕 (4147)籌碼相關-元富-桃園 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw06/0806/2207/0607/2208/0208/1608/3009/1409/2810/1210/2611/0811/2212/0612/2001/0401/1802/0802/2203/0803/1803/2804/1004/2004/3005/1205/1460708090100110Jul '24Sep '24Nov '24Mar '25May '2560d90dAll

元富-桃園 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/05/0500.00479.8079.80-41,873-0.21%
2025/05/02281.6000.0081.7021,8740.11%
2025/04/30482.1000.0081.8041,8750.21%
2025/04/2500.001080.0680.00-101,873-0.53%
2025/04/2400.00479.8079.60-41,879-0.21%
2025/04/18177.9000.0078.0011,9550.05%
2025/04/1700.00180.3079.40-12,001-0.05%
2025/04/1400.00277.4577.20-22,375-0.08%
2025/04/11473.7000.0073.8042,3770.17%
2025/04/02287.9000.0087.9022,2940.09%
2025/03/2700.00197.2096.10-12,248-0.04%
2025/03/25498.0300.0098.6042,2100.18%
2025/03/24298.30499.0099.00-22,192-0.09%
2025/03/1900.00493.3392.80-42,098-0.19%
2025/03/18191.6000.0091.9012,0850.05%
2025/03/17792.49491.9091.9032,0770.14%
2025/03/13191.5000.0091.6012,0990.05%
2025/03/1200.00297.5097.50-22,060-0.10%
2025/03/07199.1000.0096.5011,9910.05%
2025/03/0600.00194.8094.30-11,957-0.05%
2025/03/04692.6700.0095.5061,9040.32%
2025/03/032094.2000.0094.20201,8871.06%
2025/02/27195.9000.0095.5011,8780.05%
2025/02/253100.37399.9099.3001,8560.00%
2025/02/24199.1000.0099.3011,7960.06%
2025/02/213103.172101.7098.9011,7270.06%
2025/02/1700.0024.2104.7397.10-24.21,440-1.68%
2025/02/1400.00596.0098.90-51,226-0.41%
2025/02/11192.4000.0091.7011,1400.09%
2025/02/0700.00188.8090.10-11,125-0.09%
2025/02/05184.2000.0084.3011,1080.09%
2025/01/2100.00185.0084.50-11,131-0.09%
2025/01/20182.7000.0084.2011,1360.09%
2025/01/17284.7000.0084.6021,1310.18%
2025/01/14289.15288.9087.3001,1470.00%
2025/01/13191.00188.7089.9001,1320.00%
2025/01/10188.00189.2090.5001,0640.00%
2025/01/09588.06287.6087.5031,0140.30%
2025/01/0800.0011101.5097.20-11872-1.26%
2025/01/07192.301192.9792.70-10649-1.54%
2025/01/0600.00390.8089.80-3611-0.49%
2025/01/03188.90188.1088.3006000.00%
2025/01/0200.00188.1087.00-1591-0.17%
2024/12/2400.00083.5082.9005970.00%
2024/12/1700.00282.0082.00-2625-0.32%
2024/12/1200.00185.2085.10-1624-0.16%
2024/12/1100.00187.0086.00-1621-0.16%
2024/12/0900.00289.0090.10-2600-0.33%
2024/12/06388.7000.0087.6035730.52%
2024/10/28183.00282.9081.00-1584-0.17%
2024/10/24281.2500.0080.8025720.35%
2024/10/22178.5000.0080.6015620.18%
2024/09/2600.00180.9080.20-1650-0.15%
2024/09/23181.8000.0080.6016410.16%
2024/09/1100.00179.8080.40-1686-0.15%
2024/08/3000.001086.0086.40-10750-1.33%
2024/08/21381.0300.0080.9037600.39%
2024/07/2300.00886.7086.50-8746-1.07%
2024/07/1800.000.188.2088.40-0.1709-0.01%
2024/07/081086.8000.0086.00108291.21%
2024/07/0100.00190.2090.20-11,096-0.09%
2024/06/27190.1000.0089.4011,1190.09%
2024/06/1300.00191.0091.00-11,164-0.09%
2024/06/1200.00191.0091.00-11,174-0.09%
2024/06/1100.00193.0091.00-11,182-0.08%
2024/06/0700.00389.9090.10-31,167-0.26%
2024/06/03189.8000.0089.6011,3860.07%
2024/05/3100.00489.3390.10-41,420-0.28%
2024/05/3000.00389.5088.60-31,475-0.20%
2024/05/29789.460.589.1089.106.51,5110.43%
中裕首度與美國客戶簽訂CDMO合約 營運添動能Anue鉅亨-13天前
〈美對等關稅〉中裕回應暫無影響 愛滋病新藥足以供應美國市場銷售Anue鉅亨-2025/04/09
中裕長效愛滋療法主要指標達標 啟動國際授權合作Anue鉅亨-2025/03/26
中裕 相關文章